Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure

about

Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure

Item

http://www.wikidata.org/entity/Q37406578

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional characterization of ...... ment of systolic heart failure

@en

Functional characterization of ...... ent of systolic heart failure.

@nl

type

Item

label

Functional characterization of ...... ment of systolic heart failure

@en

Functional characterization of ...... ent of systolic heart failure.

@nl

prefLabel

Functional characterization of ...... ment of systolic heart failure

@en

Functional characterization of ...... ent of systolic heart failure.

@nl

P1476

Functional characterization of ...... ment of systolic heart failure

@en

P2093

Jianzhong Wang

http://www.w3.org/2001/XMLSchema#string

Na Tian

http://www.w3.org/2001/XMLSchema#string

Xiaoguang Yin

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

Yongquan Gu

http://www.w3.org/2001/XMLSchema#string

Zhihua Fang

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional reg

Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells.

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis

AKT Pathway Affects Bone Regeneration in Nonunion Treated with Umbilical Cord-Derived Mesenchymal Stem Cells.

Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

P304

3328-3332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2016.3748

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Qiang Ao

P577

2016-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27882158

http://www.w3.org/2001/XMLSchema#string

P921

systole

P932

5103788

http://www.w3.org/2001/XMLSchema#string